Kaplan–Meier survival analysis revealed that patients with glioma expressing high levels of TRIM25 exhibited worse overall survival (OS) compared to patients with lower TRIM25 expression levels (Fig. 1B). The gene discussed is TRIM25; the disease is central nervous system cancer.